|Articles|May 1, 2018
- BioPharm International-05-01-2018
- Volume 31
- Issue 5
BioPharm International, May 2018 Issue (PDF)
Click the title above to open the BioPharm International May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Harmonization of Batch Recordsalmost 8 years ago
Gottlieb Tackles Tough Issues in First Year at FDAalmost 8 years ago
Understanding Validation and Technical Transfer, Part 2almost 8 years ago
Leveraging Data for Better Biopharmaceutical Process Controlalmost 8 years ago
Key Ingredients to Healthcare’s Futurealmost 8 years ago
NIST Spectroscopic Measurement Standardsalmost 8 years ago
Managing Uncertainty in Continuous Biomanufacturingalmost 8 years ago
Putting Viral Clearance Capabilities to the Testalmost 8 years ago
CDMOs Driving Emerging Bio/Pharma SuccessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
